Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Mitigare

Generic name: Colchicine

FDA application holder: Hikma

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Mitigare?
Mitigare is a brand name of Colchicine, a prescription medicine. The FDA NDC Directory lists 1 Mitigare product in 1 strength and form.
Who makes Mitigare?
Hikma holds the FDA application for Mitigare (NDA204820, approved September 26, 2014).
Is there a generic or store brand of Mitigare?
Yes. The FDA NDC Directory lists 12 other products with the same active ingredients, strength and form as a Mitigare product, 8 of them generic. Ask your pharmacist whether one is right for you.
What do pharmacies pay for Mitigare?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Mitigare strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Mitigare been recalled?
No recall linked to Mitigare products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Mitigare is

Each Mitigare product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Colchicine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
colchicine 0.6 mg
capsule (oral)
Mitigare 12 products, 11 companies —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Colchicine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Mitigare products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA204820HikmaSeptember 26, 20141

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Mitigare, by strength and form
Strength and formGeneric or brandPharmacies pay
colchicine 0.6 mg
capsule
Brand: Mitigare $6.03 per capsule
Generic of the same strength and form: $1.69 per capsule

NADAC list of November 11, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Mitigare

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Mitigare products.

Recalls

No recall linked to Mitigare products (by their NDC code or label) appears in the FDA enforcement reports.

Next steps

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 11, 2026, retrieved November 14, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers